Abstracts Archive - Page 1167 of 2425 - ACR Meeting Abstracts

Abstract Number: 2438 • 2018 ACR/ARHP Annual Meeting
Risk and Severity of Adverse Pregnancy Outcomes in Women with Systemic Sclerosis in Taiwan
Chen I Hsieh¹, Shue Fen Luo² and Chang-Fu Kuo³, ¹Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, ²Chang Gung University, Taoyuan County, Taiwan, ³Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Background/Purpose: Patients with different autoimmune rheumatic diseases are subject to different pregnancy outcomes because of deviant immunity. Systemic sclerosis is known to be associated with…
Abstract Number: 2439 • 2018 ACR/ARHP Annual Meeting
A Description of Contraception Practices in the Ohio State University Lupus Cohort
Veronica Mruk¹, Ashlee Weaver², Alexa Zofia³, Emily Sullivan⁴, Kelly Morris⁵, Stacy P. Ardoin⁶, Elise Berlan⁷ and Alexa Meara⁸, ¹The Nationwide Children's Hospital, Columbus, OH, ²The Ohio State University School of Medicine, Columbus, OH, ³The Ohio State University, Columbus, OH, ⁴The Ohio State Univeristy Wexner Medical Center, Columbus, OH, ⁵Rheumatology and Immunology, The Ohio State University, Columbus, OH, ⁶The Ohio State University Wexner Medical Center, Columbus, OH, ⁷Adolescent Medicine, Nationwide Children's Hospital, columbus, OH, ⁸Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease, which predominantly affects women and reaches peak incidence during reproductive years. Periods of high…
Abstract Number: 2440 • 2018 ACR/ARHP Annual Meeting
Outcomes of Pregnancy Complicated By ANCA-Associated Vasculitis: A Retrospective Review
Jennifer Strouse¹, Melissa Swee², Manish Suneja¹ and Bharat Kumar³, ¹Internal Medicine, University of Iowa, Iowa City, IA, ²Transplant Nephrology, University of Iowa, Iowa City, IA, ³Internal Medicine-Division of Immunology, University of Iowa, Iowa City, IA
Background/Purpose: ANCA-Associated Vasculitis (AAV) is a small-vessel vasculitis that predominantly affects the kidneys, lungs, and sinuses, among other organs. It has been traditionally associated with…
Abstract Number: 2441 • 2018 ACR/ARHP Annual Meeting
Needs and Barriers to Pregnancy Counselling in Women with SLE
Autumn Neville¹, Natalie Dayan¹, Cheryl Barnabe², Susan Elliott³, Laurie Proulx⁴, Deborah Da Costa⁵, Sasha Bernatsky⁶ and Evelyne Vinet⁷, ¹McGill University Health Centre, Montreal, QC, Canada, ²Medicine, University of Calgary, Calgary, AB, Canada, ³GEOGRAPHY AND ENVIRONMENTAL MANAGEMENT, University of Waterloo, Waterloo, ON, Canada, ⁴Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, ⁵Medicine, McGill University, Montreal, QC, Canada, ⁶Divisions of Rheumatology and Clinical Epidemiology, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ⁷Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Existing data suggest that barriers to pregnancy counselling exist and might represent an area of need in order to optimize outcomes for SLE pregnancies.…
Abstract Number: 2442 • 2018 ACR/ARHP Annual Meeting
Familial Mediterranean Fever Associated Infertility and Underlying Factors with Fertility
Nuh Atas¹, Berkan Armagan², Erdal Bodakci³, Timucin Kasifoglu⁴, Hasan Satis¹, Alper Sari², Nazife Sule Yasar Bilge³, Hakan Babaoglu¹, Gozde Yardımcı², Reyhan Salman¹, Levent Kilic², Abdurrahman Tufan¹, Mehmet Akif Ozturk¹, Berna Goker¹, Seminur Haznedaroglu¹ and Umut Kalyoncu², ¹Internal Medicine-Rheumatology, Gazi University Faculty of Medicine, Ankara, Turkey, ²Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ³Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, ⁴Department of Internal Medicine, Division of Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey
Background/Purpose: Familial Mediterranean Fever (FMF) is the most frequent auto-inflammatory disease caused by MEFV gene mutations. Although disease is characterized by intermittent febrile inflammatory attacks…
Abstract Number: 2443 • 2018 ACR/ARHP Annual Meeting
Trends in the Incidence of Lymphomas and Leukemias in Patients with Rheumatoid Arthritis in Spain: An Observational Cohort Study of Hospital Discharges from 1999 to 2015
J.L Morell-Hita¹, Ramon Mazzucchelli², E Perez-Fernandez², Javier Quirós², Cristina Macia-Villa³, Natalia Crespí⁴, M Peña², Carmen Barbadillo⁵, Maria Espinosa⁶, Hilda Godoy⁵, Manuel Fernández⁷, María Galindo⁸, Alberto Garcia-Vadillo⁹, O Guzon-Illescas², Angela Herranz¹⁰, Cristina Martinez-Prada¹¹, C Morado-Quiñoa¹¹ and Virginia Villaverde García¹², ¹H.U.Ramón y Cajal, Madrid, Spain, ²H.U.Fundación Alcorcón, Madrid, Spain, ³Hospital Universitario Severo Ochoa, Madrid, Spain, ⁴C.S. La Rivota, Madrid, Spain, ⁵H.U. Puerta de Hierro, Madrid, Spain, ⁶Rheumatology, H.U. Puerta de Hierro, Madrid, Spain, ⁷Hospital Universitario de Guadalajara. Spain, Guadalajara, Spain, ⁸Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, ⁹Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ¹⁰H.U. del Henares, Madrid, Spain, ¹¹H.U. Clínico San Carlos, Madrid, Spain, ¹²Rheumatology, Hospital Universitario de Móstoles, Móstoles, Spain
Background/Purpose: Oncohematological diseases have an increased incidence in Rheumatoid Arthritis (RA) patients. In the last years numerous studies have appeared exploring the relationship between these…
Abstract Number: 2444 • 2018 ACR/ARHP Annual Meeting
The Risk of Solid Cancers in Patients with Rheumatoid Arthritis Exposed to Biologic Dmards with/without Prior Cancers
Masaomi Yamasaki, Rheumatology, Shin-Yokohama Arthritis and Rheumatology Clinic, Yokohama, Japan
Background/Purpose: To compare the risk of solid cancer in patient with rheumatoid arthritis treated with biologic disease modifying antirheumatic drugs(b-DMARDs) to that in patients treated…
Abstract Number: 2445 • 2018 ACR/ARHP Annual Meeting
The Effect of Biologic Agents on Hemoglobin Levels of Patients with Rheumatoid Arthritis
Hwajeong Lee¹, Jung-Yoon Choe², Seong-Kyu Kim³ and Seonghoon Park⁴, ¹Division of Rheumatology, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea, Republic of (South), ²Daegu Catholic University School of Medicine, Daegu, Korea, Republic of (South), ³Rheumatology, Daegu Catholic University School of Medicine, Daegu, Korea, Republic of (South), ⁴Medicine, Daegu Catholic University School of Medicine, Daegu, Korea, Republic of (South)
Background/Purpose: Anemia is not considered a major problem in rheumatoid arthritis. But prevalence data suggest that 30-70% of rheumatoid arthritis(RA) patients have anemia. Inflammatory cytokines…
Abstract Number: 2446 • 2018 ACR/ARHP Annual Meeting
The Combined Use of Folic Acid Influenced the Time until the Development of Lymphoproliferative Disorders in Patients with Rheumatoid Arthritis during Treatment with Methotrexate
Sho Sasaki¹, Yasushi Kondo², Yasuo Suzuki³, Takayoshi Kurabayashi¹, Yasushi Koyama¹, Yuto Izumi¹, Yoko Nakagome¹, Kazuki Hirano¹, Chiho Yamada¹ and Shinji Sato¹, ¹Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan, ²Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Tokyo, Japan, ³Division of Rheumatology, Department of Internal Medicine, Tokai University Hachioji Hospital, Hachioji, Japan, Isehara, Japan
Background/Purpose: Lymphoproliferative disorders (LPDs) are a serious complication in patients with rheumatoid arthritis (RA). Methotrexate (MTX) is known to be able to cause a development…
Abstract Number: 2447 • 2018 ACR/ARHP Annual Meeting
Liver Enzyme Abnormalities after Tofacitinib Treatment in Patients with Hepatic Steatosis from the Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis Clinical Programs
Enrique R Soriano¹, Hugo Madariaga², Oswaldo Castañeda³, Gustavo Citera⁴, Emilce E Schneeberger⁴, Mario H Cardiel⁵, Thijs Hendrikx⁶, Daniela Graham⁷, Harry Shi⁶ and Dario Ponce de Leon⁸, ¹Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²Clínica del Sur, Arequipa, Peru, ³Clínica Anglo Americana, Lima, Peru, ⁴Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁵Centro de Investigación Clínica de Morelia, Morelia, Mexico, ⁶Pfizer Inc, Collegeville, PA, ⁷Pfizer Inc, Groton, CT, ⁸Pfizer Inc, Lima, Peru
Background/Purpose: Non-alcoholic fatty liver disease, characterized by hepatic steatosis (HS), is a very common form of chronic liver disease in many countries. Limited data are…
Abstract Number: 2448 • 2018 ACR/ARHP Annual Meeting
Correlation between Long-Term Low-Dose Steroid Administration and Reactivation of Hepatitis B Virus in Patients with Rheumatoid Arthritis
WooSeong Jeong¹, Jinseok Kim², Byeongzu Ghang¹ and Byung Cheol Song³, ¹Division of Rheumatology, Department of Internal Medicine, Jeju National University Hospital, University of Jeju School of Medicine, Jeju, Korea, Republic of (South), ²Department of Medicine, Jeju National University Hospital, University of Jeju School of Medicine, Jeju, Korea, Republic of (South), ³Department of gastroenterology, Departments of Internal Medicine, Jeju National University Hospital, University of Jeju School of Medicine, Jeju, Korea, Republic of (South)
Background/Purpose: It is well known that the use of corticosteroids results in increased viral replication and elevated ALT in patients with hepatitis B virus. The…
Abstract Number: 2449 • 2018 ACR/ARHP Annual Meeting
Prevalence and Risk Factors of Serious Infections in Rheumatoid Arthritis Patients Receiving the Biologic/Targeted Synthetic Dmards: A Propensity Score Analysis from the Hong Kong Biologics Registry
Chi Chiu Mok, Ting Hung Wan and Lai Shan Fong, Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong
Background/Purpose: To study the prevalence and risk factors for serious infections (SIs) in rheumatoid arthritis (RA) patients receiving the biologic / target synthetic (b/ts) DMARDs.…
Abstract Number: 2450 • 2018 ACR/ARHP Annual Meeting
Prosthetic Joint Infection in Patients with Rheumatoid Arthritis
John Fredy Jaramillo Gallego¹, Aurelia Luissi¹, Marina Scolnik², Javier Rosa¹ and Enrique R Soriano², ¹Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Capital Federal, Argentina, ²Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina
Background/Purpose: Patients with rheumatoid arthritis (RA) have been shown to have an increased susceptibility to the development of prosthetic joint infection (PJI) after Total Hip…
Abstract Number: 2451 • 2018 ACR/ARHP Annual Meeting
Herpes Zoster in Rheumatoid Arthritis. Prospective Single Center Study of 390 RA Patients for 5 YEARS
Lucia C. Domínguez-Casas¹, Vanesa Calvo-Río², Paz Rodríguez-Cundín³, Virginia Portilla⁴, Nuria Vegas-Revenga², F. Antolin⁵, M. Rebollo-Rodrigo³, Alfonso Corrales¹, Diana Prieto Peña², Monica Calderón Goercke², Miguel Angel González-Gay⁶ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Preventive Medicine, Preventive Medicine. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain., Santander, Spain, ⁴Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁵Preventive Medicine. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain., Santander, Spain, ⁶Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Immunosuppressed patients such as Rheumatoid Arthritis (RA) patients have a greater risk (1.5-2 times) of presenting herpes zoster (HZ). Both, the disease itself and…
Abstract Number: 2452 • 2018 ACR/ARHP Annual Meeting
Incidence Rate and Clinical Characteristics of Herpes Zoster Infection in Korean Patients with Rheumatoid Arthritis Patients
Su-Jin Moon¹, Min Jung Kim², Sun Kyung Lee², So Hee Oh², Hyoun-Ah Kim³ and Kichul Shin⁴, ¹Bucheon St. Mary's Hospital, Division of rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South), ²Division of Rheumatology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of (South), ³Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea, Republic of (South), ⁴Kyungnam villa #102, Division of Rheumatology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of (South)
Background/Purpose: Herpes zoster (HZ) infection is not uncommon in rheumatoid arthritis (RA) patients, especially in those treated with biologic or targeted synthetic (bts) disease-modifying antirheumatic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].